Clinical Trial Update: The PK/PD, Efficacy, Safety and Tolerability Study of SHR3824 in Type 2 Diabetes Mellitus Patients [Phase 1]

View source ↗

Summary

This entry provides a Phase 1 update on SHR3824, covering pharmacokinetic/pharmacodynamic characteristics as well as preliminary efficacy, safety and tolerabili…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SHR3824

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: UNKNOWN